SOHO-02: Phase III Trial of BAY 2927088 in Patients with Locally Advanced or Metastatic NSCLC with HER2-Activating Mutations

K. Goto,J. C. Brase, J. Xu, S. -F. Pu, M. Montague-Dale,L. Mongay Soler,A. Passaro

JOURNAL OF THORACIC ONCOLOGY（2024）

Cited 0|Views1

Key words

NSCLC,Phase III,HER2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined